Zimmer Biomet Beats Expectations for Early 2022

Zimmer Biomet reported 1Q22 orthopedic sales of $1.66 billion, +3.9% vs. 1Q21.

In the company's first quarter since spinning off its spine and dental businesses, Zimmer Biomet benefitted from a faster than expected elective procedure recovery as COVID relents in parts of the world. The rebound of elective procedures more than offset other...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us